Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Reata Pharmaceuticals Inc...

    NASDAQ: RETA · Real-Time Price · USD
    172.36
    0.04 (0.02%)
    At close: Sep 25, 2023, 10:00 PM

    Reata Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -311.9M -297.39M
    Depreciation & Amortization
    		 1.13M 1.2M
    Stock-Based Compensation
    		 58.73M 56.81M
    Other Working Capital
    		 4.11M -58.29M
    Other Non-Cash Items
    		 38.46M 53.25M
    Deferred Income Tax
    		 n/a n/a
    Change in Working Capital
    		 9.31M -49.58M
    Operating Cash Flow
    		 -204.27M -235.7M
    Capital Expenditures
    		 -3.27M -1.33M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 -661.89M n/a
    Sales Maturities Of Investments
    		 320M n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 -345.16M -1.33M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 1.49M 9.14M
    Financial Cash Flow
    		 1.49M 9.14M
    Net Cash Flow
    		 -547.95M -227.89M
    Free Cash Flow
    		 -207.54M -237.03M

    Add to Watchlist